No­var­tis strikes ra­dio­phar­ma deal with Ra­tio worth up to $745M

No­var­tis is mak­ing an­oth­er pact in ra­dio­phar­ma, promis­ing as much as $745 mil­lion to a Boston-based start­up.

Ra­tio Ther­a­peu­tics will get an undis­closed up­front pay­ment …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER